| Citation: |
LIU Xuan, CHEN Linfeng. Analysis of factors related to the occurrence time of common clinical adverse reactions for blood transfusion[J]. Journal of Clinical Medicine in Practice, 2022, 26(16): 105-107. DOI: 10.7619/jcmp.20220431
|
To explore the factors related to the occurrence time of common adverse blood transfusion reactions (allergic blood transfusion reaction, non-hemolytic febrile blood transfusion reaction).
The data of 80 patients with adverse reactions related to blood transfusion were retrospectively analyzed (with 78 patients included eventually). According to the clinical medication, the patients were divided into antihistamine group (n=19, promethazine or diphenhydramine), dexamethasone group (n=32) and no medication group (n=27). The occurrence time of adverse reactions was observed and compared among the three groups.
The occurrence time of transfusion adverse reactions in the antihistamine group was significantly later than that in the dexamethasone group and no drug group (P < 0.05). The occurrence time of adverse reactions in patients with history of blood transfusion was significantly later than that in patients without history of blood transfusion (P < 0.05). The occurrence time of transfusion adverse reactions in patients with 5 or more transfusions during hospitalization was significantly earlier than that in patients with less than 5 transfusions (P < 0.05). The adverse reaction time of transfusion in patients with suspended red blood cell infusion was significantly later than that in patients with normal plasma and apheresis platelet infusion (P < 0.05). The occurrence time of anaphylactic blood transfusion reaction in patients with normal plasma infusion was significantly earlier than that in patients with suspended red blood cell infusion (P < 0.05).
Prophylactic use of antihistamines before transfusion can lead to a delay in the occurrence of common transfusion adverse reactions. The time of common transfusion adverse reactions in patients with multiple blood transfusions and infusion of different blood components differs, so it is necessary to be careful to use preventive drugs and choose blood products reasonably before transfusion.
| [1] |
DELANEY M, WENDEL S, BERCOVITZ R S, et al. Transfusion reactions: prevention, diagnosis, and treatment[J]. Lancet, 2016, 388(10061): 2825-2836. doi: 10.1016/S0140-6736(15)01313-6
|
| [2] |
中国输血协会临床输血学专业委员会《血液成分输注临床路径》制订协作组. 血液成分输注临床路径专家共识(2018年)[J]. 临床血液学杂志, 2018, 31(2): 81-84. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXZ201802001.htm
|
| [3] |
刘景汉, 汪德清. 临床输血学[M]. 北京: 人民卫生出版社, 2011: 1-10.
|
| [4] |
黄爱群, 孙凯, 陈惠红, 等. 输血不良反应的发生率及相关影响因素[J]. 实用医学杂志, 2020, 36(12): 1665-1668. doi: 10.3969/j.issn.1006-5725.2020.12.023
|
| [5] |
徐燕娜, 纪勇平, 杨慧, 等. 常见输血不良反应发生率及相关危险因素探讨[J]. 中国卫生检验杂志, 2019, 29(6): 757-759. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWJZ201906038.htm
|
| [6] |
尹明伟, 徐军, 曾智, 等. 331名患儿输血不良反应调查及影响因素分析[J]. 中国输血杂志, 2018, 31(2): 184-186. https://www.cnki.com.cn/Article/CJFDTOTAL-BLOO201802029.htm
|
| [7] |
刘丽娟, 杜肖刚, 王丽荣, 等. 输血前预防性用药对输血不良反应的影响[J]. 临床输血与检验, 2017, 19(6): 559-561. doi: 10.3969/j.issn.1671-2587.2017.06.008
|
| [8] |
徐慧英, 朱蕾, 廖昭平. 输血不良反应98例分析[J]. 实用医技杂志, 2018, 25(1): 5-8. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYJ201801001.htm
|
| [9] |
薛雷. 输血前预防性用药对输血过敏反应的影响分析[J]. 中国实用医药, 2014, 9(19): 174-175. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSSA201419128.htm
|
| [10] |
FUNG M K, HEDDLE N M. Febrile and allergic transfusion reactions[M]//Practical Transfusion Medicine. Oxford, UK: John Wiley & Sons, Ltd, 2013: 89-96.
|
| [11] |
NING S Y, SOLH Z, ARNOLD D M, et al. Premedication for the prevention of nonhemolytic transfusion reactions: a systematic review and meta-analysis[J]. Transfusion, 2019, 59(12): 3609-3616. doi: 10.1111/trf.15566
|
| [12] |
COGNASSE F, GARRAUD O. Cytokines and related molecules, and adverse reactions related to platelet concentrate transfusions[J]. Transfus Clin Biol, 2019, 26(3): 144-146. doi: 10.1016/j.tracli.2019.06.324
|
| [13] |
贾波. 非传染性输血不良反应与用血量、输血人次、输血品种的关系探讨[J]. 临床研究, 2020, 28(5): 9-11. https://www.cnki.com.cn/Article/CJFDTOTAL-LCYN202005004.htm
|
| [14] |
ALOUI C, BARLIER C, CLAVEROL S, et al. Differential protein expression of blood platelet components associated with adverse transfusion reactions[J]. J Proteomics, 2019, 194: 25-36. doi: 10.1016/j.jprot.2018.12.019
|
| [15] |
葛云萍, 李争艳, 王薇, 等. 输血品种、输血次数与非传染性输血不良反应的关系[J]. 临床血液学杂志: 输血与检验, 2017, 30(3): 478-479. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXZ201706023.htm
|
| [16] |
唐聪海, 黄燕雪, 林艺璇, 等. 输血不良反应相关因素分析[J]. 中国实验血液学杂志, 2020, 28(3): 972-976. https://www.cnki.com.cn/Article/CJFDTOTAL-XYSY202003047.htm
|
| 1. |
杨斌，夏克明，韩飞. 骨科创伤性失血患者输血不良反应调查及危险因素分析. 中国当代医药. 2024(10): 131-134 .
| |
| 2. |
张媚琰，顾屏，李婷婷. 输血不良反应发生的现状分析及影响因素调查. 中国医学创新. 2024(31): 175-178 .
| |
| 3. |
王胜蓝，贵明飞，华敏玉，李鹏，卓创近，刘钟梅，杨霞，黄霞，何涛. 急性输血不良反应发生时间调查及分析. 临床输血与检验. 2023(01): 33-37 .
| |
| 4. |
陆国健，吴文强，廖阳东，王晓刚，陆春兰. 基于凝血指标、血栓弹力图构建急性再生障碍性贫血患者输血不良反应发生风险预测模型及其验证. 东南大学学报(医学版). 2023(05): 673-680 .
| |
| 5. |
赖志辉. 探讨预防性用药对降低输血不良反应发生率所产生的影响. 北方药学. 2023(09): 146-148 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: